However, differences in age distributions by ER-receptor status were not as pronounced as have been observed in high-risk populations such as the United States (younger distribution for ERN tumors) [17,21]; thus ER proportions by age would benefit from re-investigation in other large breast cancer case series from Africa. This evidence concerns the gene ESR1 and breast carcinoma.